MUN36378
CAS No. 2243736-37-8
MUN36378( —— )
Catalog No. M28934 CAS No. 2243736-37-8
MUN36378 is a FTO inhibitor for treatment of leukemia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 255 | Get Quote |
|
10MG | 357 | Get Quote |
|
25MG | 597 | Get Quote |
|
50MG | 851 | Get Quote |
|
100MG | 1152 | Get Quote |
|
500MG | 2313 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMUN36378
-
NoteResearch use only, not for human use.
-
Brief DescriptionMUN36378 is a FTO inhibitor for treatment of leukemia.
-
DescriptionMUN36378 is a FTO inhibitor for treatment of leukemia.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorHDAC6
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2243736-37-8
-
Formula Weight376.24
-
Molecular FormulaC18H15Cl2N3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc([nH]nc1C)c1-c(cc1Cl)cc(Cl)c1Nc(cccc1)c1C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Krukowski K, et al. HDAC6 inhibition effectively reverses chemotherapy-induced peripheral neuropathy. Pain. 2017 Jun;158(6):1126-1137.
molnova catalog
related products
-
6-Hydroxykaempferol ...
6-Hydroxykaempferol 3-O-beta-D-glucoside has anti-thrombotic,and antioxidative activities.
-
INDY
INDY is an ATP-competitive inhibitor of Dyrk1A and Dyrk1B with IC50s of 0.24 μM and 0.23 μM and a Ki of 0.18 μM for Dyrk1A ATP pocket, respectively.
-
Biatractylolide
Biatractylolide has a neuroprotective effect on glutamate-induced injury in PC12 and SH-SY5Y cells through a mechanism of the PI3K-Akt-GSK3β-dependent pathways.